Kent State University, Department of Psychological Sciences, Kent, OH, USA.
Oriana House Alcohol, Drug Addiction, and Mental Health Crisis Center, Akron, OH, USA.
J Subst Abuse Treat. 2018 Mar;86:45-51. doi: 10.1016/j.jsat.2017.12.009. Epub 2017 Dec 19.
Poly-substance use and psychiatric comorbidity are common among individuals receiving substance detoxification services. Posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) are the most common co-occurring psychiatric disorders with substance use disorder (SUD). Current treatment favors a one-size-fits-all approach to treating addiction focusing on one substance or one comorbidity. Research examining patterns of substance use and comorbidities can inform efforts to effectively identify and differentially treat individuals with co-occurring conditions.
Using latent class analysis, the current study identified four patterns of PTSD, MDD, and substance use among 375 addiction treatment seekers receiving medically supervised detoxification.
The four identified classes were: 1) a PTSD-MDD-Poly SUD class characterized by PTSD and MDD occurring in the context of opioid, cannabis, and tobacco use disorders; 2) an MDD-Poly SUD class characterized by MDD and alcohol, opioid, tobacco, and cannabis use disorders; 3) an alcohol-tobacco class characterized by alcohol and tobacco use disorders; and 4) an opioid-tobacco use disorder class characterized by opioid and tobacco use disorders. The observed classes differed on gender and clinical characteristics including addiction severity, trauma history, and PTSD/MDD symptom severity.
The observed classes likely require differing treatment approaches. For example, people in the PTSD-MDD-Poly SUD class would likely benefit from treatment approaches targeting anxiety sensitivity and distress tolerance, while the opioid-tobacco class would benefit from treatments that incorporate motivational interviewing. Appropriate matching of treatment to class could optimize treatment outcomes for polysubstance and comorbid psychiatric treatment seekers. These findings also underscore the importance of well-developed referral networks to optimize outpatient psychotherapy for detoxification treatment-seekers to enhance long-term recovery, particularly those that include transdiagnostic treatment components.
在接受物质戒毒服务的人群中,多物质使用和精神共病较为常见。创伤后应激障碍(PTSD)和重性抑郁障碍(MDD)是与物质使用障碍(SUD)最常见的共病精神障碍。目前的治疗方法倾向于对所有成瘾者采用一刀切的方法,侧重于一种物质或一种共病。研究检查物质使用和共病模式可以为有效识别和差异化治疗共病个体提供信息。
本研究使用潜在类别分析,在接受医学监督下脱毒治疗的 375 名成瘾治疗寻求者中,确定了 PTSD、MDD 和物质使用的四种模式。
确定了四个类别:1)PTSD-MDD-多物质使用障碍(SUD)类,特征为 PTSD 和 MDD 发生在阿片类药物、大麻和烟草使用障碍的背景下;2)MDD-多物质使用障碍类,特征为 MDD 和酒精、阿片类药物、烟草和大麻使用障碍;3)酒精-烟草类,特征为酒精和烟草使用障碍;4)阿片类药物-烟草使用障碍类,特征为阿片类药物和烟草使用障碍。观察到的类别在性别和临床特征上存在差异,包括成瘾严重程度、创伤史和 PTSD/MDD 症状严重程度。
观察到的类别可能需要不同的治疗方法。例如,PTSD-MDD-多物质使用障碍(SUD)类别的人可能会受益于针对焦虑敏感性和痛苦耐受力的治疗方法,而阿片类药物-烟草类别的人可能会受益于纳入动机性访谈的治疗方法。将治疗方法与类别相匹配可以优化多物质和共病精神治疗寻求者的治疗效果。这些发现还强调了建立完善的转介网络的重要性,以优化脱毒治疗寻求者的门诊心理治疗,从而提高长期康复率,特别是那些包括跨诊断治疗成分的网络。